These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23440955)

  • 1. Axiomatic foundations for cost-effectiveness analysis.
    Canning D
    Health Econ; 2013 Dec; 22(12):1405-16. PubMed ID: 23440955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the lottery equivalents method: a response to Spencer et al.
    Oliver A
    Health Econ; 2006 Mar; 15(3):323-5. PubMed ID: 16432804
    [No Abstract]   [Full Text] [Related]  

  • 3. In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'.
    Richardson JR; Olsen JA
    Health Econ; 2006 Mar; 15(3):311-3; discussion 319-22. PubMed ID: 16389655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axioms for health care resource allocation.
    Osterdal LP
    J Health Econ; 2005 Jul; 24(4):679-702. PubMed ID: 15960991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent income and fair evaluation of health care.
    Fleurbaey M; Luchini S; Muller C; Schokkaert E
    Health Econ; 2013 Jun; 22(6):711-29. PubMed ID: 22767541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Welfare economics and cost-utility analysis.
    Butler JR
    Dev Health Econ Public Policy; 1992; 1():143-57. PubMed ID: 10151743
    [No Abstract]   [Full Text] [Related]  

  • 8. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults.
    Bachmann MO
    AIDS Care; 2006 Feb; 18(2):109-20. PubMed ID: 16338768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-social welfare functions: a reply to Hansen et al.
    Edlin R
    J Health Econ; 2004 Sep; 23(5):899-905. PubMed ID: 15353185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of captopril therapy after myocardial infarction.
    Tsevat J; Duke D; Goldman L; Pfeffer MA; Lamas GA; Soukup JR; Kuntz KM; Lee TH
    J Am Coll Cardiol; 1995 Oct; 26(4):914-9. PubMed ID: 7560617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allocating health care resources when people are risk averse with respect to life time.
    Hoel M
    Health Econ; 2003 Jul; 12(7):601-8. PubMed ID: 12825211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness in primary health care in Greece.
    Diomidous M; Gougoumati K; Kalokairinou A
    Stud Health Technol Inform; 2013; 190():225-7. PubMed ID: 23823430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cost effectiveness analysis in health care evaluation.
    Atherly A; Culler SD; Becker ER
    Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting.
    Zhang Y; Kivipelto M; Solomon A; Wimo A
    J Alzheimers Dis; 2011; 26(4):735-44. PubMed ID: 21709377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philosophical concerns regarding cost-effectiveness analyses.
    Weiner BK
    Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is economic evaluation in touch with society's health values?
    Coast J
    BMJ; 2004 Nov; 329(7476):1233-6. PubMed ID: 15550430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost-Effectiveness Analysis.
    van Baal P; Meltzer D; Brouwer W
    Health Econ; 2016 Feb; 25(2):237-48. PubMed ID: 25533778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
    Dolan P; Edlin R
    J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.